CCL2 and amyloidosis: Notably, MCP-1 neuronal levels are upregulated before the development of amyloid plaques in a transgenic rat model of the AD-like pathology and in Aβ-burdened neurons in the human cerebral cortex [9], supporting its early involvement at incipient stages of amyloid accumulation.